Journal of Drug Targeting

Papers
(The TQCC of Journal of Drug Targeting is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
A comprehensive review on the antiviral activities of chalcones59
CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia54
Mesoporous silica nanoparticles: synthesis methods and their therapeutic use-recent advances50
Carbon-based nanomaterials for targeted cancer nanotherapy: recent trends and future prospects48
Thymoquinone and curcumin combination protects cisplatin-induced kidney injury, nephrotoxicity by attenuating NFκB, KIM-1 and ameliorating Nrf2/HO-1 signalling42
A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances33
Pharmacological and non-pharmacological efforts at prevention, mitigation, and treatment for COVID-1931
New advances in brain-targeting nano-drug delivery systems for Alzheimer's disease31
Improved oral delivery of quercetin with hyaluronic acid containing niosomes as a promising formulation31
Non-surgical osteoarthritis therapy, intra-articular drug delivery towards clinical applications27
The relevant targets of anti-oxidative stress: a review27
Stability issues and approaches to stabilised nanoparticles based drug delivery system27
Polo-like Kinase 1 as an emerging drug target: structure, function and therapeutic implications27
3D printing technology in healthcare: applications, regulatory understanding, IP repository and clinical trial status27
Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety26
Current status of micro/nanomotors in drug delivery25
Targetting ferroptosis for blood cell-related diseases25
Bioengineered smart bacterial carriers for combinational targeted therapy of solid tumours24
Fabrication and characterisation of self-applicating heparin sodium microneedle patches24
Improving anti-tumour efficacy of PEGylated liposomal doxorubicin by dual targeting of tumour cells and tumour endothelial cells using anti-p32 CGKRK peptide23
ABC transporters in breast cancer: their roles in multidrug resistance and beyond23
Potential inhibitors of SARS-CoV-2: recent advances23
Manganese dioxide (MnO2) based nanomaterials for cancer therapies and theranostics23
Active-site molecular docking of nigellidine with nucleocapsid–NSP2–MPro of COVID-19 and to human IL1R–IL6R and strong antioxidant role of Nigella sativa in experimental rats22
Mitochondria autophagy: a potential target for cancer therapy22
Niosomal formulation for antibacterial applications21
Dual functional nanoparticles efficiently across the blood–brain barrier to combat glioblastoma via simultaneously inhibit the PI3K pathway and NKG2A axis20
Nano drug delivery system reconstruct tumour vasculature for the tumour vascular normalisation20
An updated review on exosomes: biosynthesis to clinical applications19
Cationic liposome decorated with cyclic RGD peptide for targeted delivery of anti-STAT3 siRNA to melanoma cancer cells18
Mitochondrial delivery of microRNA mimic let-7b to NSCLC cells by PAMAM-based nanoparticles18
Core-shell nanotherapeutics with leukocyte membrane camouflage for biomedical applications18
Empagliflozin alleviates myocardial I/R injury and cardiomyocyte apoptosis via inhibiting ER stress-induced autophagy and the PERK/ATF4/Beclin1 pathway18
Depleting microRNA-146a-3p attenuates lipopolysaccharide-induced acute lung injury via up-regulating SIRT1 and mediating NF-κB pathway18
Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer’s disease in intracerebroventricular streptozotocin model for brain delivery18
A γ-cyclodextrin-based metal–organic framework (γ-CD-MOF): a review of recent advances for drug delivery application17
Nanomedicine and chemotherapeutics drug delivery: challenges and opportunities16
Nanoliposomes as drug delivery systems: safety concerns16
New insights into the role of co-receptor neuropilins in tumour angiogenesis and lymphangiogenesis and targeted therapy strategies16
Methods for fabricating oxygen releasing biomaterials16
MicroRNA-185 activates PI3K/AKT signalling pathway to alleviate dopaminergic neuron damage via targeting IGF1 in Parkinson’s disease16
EGFR and anti-EGFR nanobodies: review and update15
Genetically engineered exosomes display RVG peptide and selectively enrich a neprilysin variant: a potential formulation for the treatment of Alzheimer’s disease15
A novel progress of drug delivery system for organelle targeting in tumour cells15
Advancements of compounds targeting Wnt and Notch signalling pathways in the treatment of inflammatory bowel disease and colon cancer15
Mesencephalic astrocyte-derived neurotrophic factor restores blood–brain barrier integrity of aged mice after ischaemic stroke/reperfusion through anti-inflammation via TLR4/MyD88/NF-κB pathway15
Micro and nanorobot-based drug delivery: an overview15
Exosome-mediated transfer of circHIPK3 promotes trastuzumab chemoresistance in breast cancer15
PEGylated DOX-coated nano graphene oxide as pH-responsive multifunctional nanocarrier for targeted drug delivery14
Targeting PRAS40: a novel therapeutic strategy for human diseases14
The role of peptide-based therapeutics in oncotherapy14
Biomedical application of chondroitin sulfate with nanoparticles in drug delivery systems: systematic review14
The mechanisms of lncRNA GAS5 in cardiovascular cells and its potential as novel therapeutic target14
Progress in tumour-targeted drug delivery based on cell-penetrating peptides14
Erlotinib entrapped in cholesterol-depleting cyclodextrin nanoparticles shows improved antitumoral efficacy in 3D spheroid tumors of the lung and the liver14
Influences of different sugar ligands on targeted delivery of liposomes14
Immunotoxins and nanobody-based immunotoxins: review and update14
Effect of polymer microneedle pre-treatment on drug distributions in the skin in vivo13
Inhibition of microRNA-10b-5p up-regulates HOXD10 to attenuate Alzheimer’s disease in rats via the Rho/ROCK signalling pathway13
Iron metabolism in Pseudomonas aeruginosa biofilm and the involved iron-targeted anti-biofilm strategies13
A mechanistic perspective on targeting bacterial drug resistance with nanoparticles13
Innovative topical niosomal gel formulation containing diclofenac sodium (niofenac)13
Efficient antiglioblastoma therapy in mice through doxorubicin-loaded nanomicelles modified using a novel brain-targeted RVG-15 peptide12
Delivery of RGD-modified liposome as a targeted colorectal carcinoma therapy and its autophagy mechanism12
Exosome vesicle as a nano-therapeutic carrier for breast cancer12
Autophagy: a killer or guardian of vascular smooth muscle cells12
Cellular assays and applied technologies for characterisation of orally administered protein nanoparticles: a systematic review12
New generation of viral nanoparticles for targeted drug delivery in cancer therapy12
Bevacizumab combined with apatinib enhances antitumor and anti-angiogenesis effects in a lung cancer model in vitro and in vivo12
TIGIT/PVR and LncRNA ANRIL dual-targetable PAMAM polymeric nanoparticles efficiently inhibited the hepatoma carcinoma by combination of immunotherapy and gene therapy12
Effects and mechanisms of natural plant active compounds for the treatment of osteoclast-mediated bone destructive diseases12
Functionality of receptor targeted zinc-insulin quantum clusters in skin tissue augmentation and bioimaging12
Non-ionic surfactant vesicles as a carrier system for dermal delivery of (+)-Catechin and their antioxidant effects12
MicroRNA-135b-5p promotes endothelial cell proliferation and angiogenesis in diabetic retinopathy mice by inhibiting Von Hipp-el-Lindau and elevating hypoxia inducible factor α expression12
Envelope proteins as antiviral drug target12
Formulation development of tocopherol polyethylene glycol nanoengineered polyamidoamine dendrimer for neuroprotection and treatment of Alzheimer disease11
Sirtuins as therapeutic targets for improving delayed wound healing in diabetes11
Role of exosomes in tumour growth, chemoresistance and immunity: state-of-the-art11
Mitochondrial dysfunction and mitochondrion-targeted therapeutics in liver diseases11
Opportunities and obstacles of targeted therapy and immunotherapy in small cell lung cancer11
Hyaluronic acid-coated metal-organic frameworks benefit the ROS-mediated apoptosis and amplified anticancer activity of artesunate11
Mycobacterial ethambutol responsive genes and implications in antibiotics resistance11
Enzyme-instructed self-assembly of the stereoisomers of pentapeptides to form biocompatible supramolecular hydrogels11
Significant metabolic alterations in patients with hepatitis B virus replication observed via serum untargeted metabolomics shed new light on hepatitis B virus infection11
0.023501873016357